Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RP103 in children with inherited mitochondrial disease
NCT02023866Phase 2Completed
- Sponsor
- Amgen
- Start
- May 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cysteamine in inherited mitochondrial disease, sponsored by Amgen. Started May 2014; status: completed.
02
Drugs
cysteamine
03
Conditions
inherited mitochondrial disease
Beyond the preview
Go deeper on NCT02023866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023866.